How Many Inovalon Holdings, Inc. (NASDAQ:INOV)’s Analysts Are Bullish?

June 3, 2018 - By Marie Mckinney

Inovalon Holdings, Inc. (NASDAQ:INOV) Logo

Inovalon Holdings, Inc. (NASDAQ:INOV) Ratings Coverage

Among 3 analysts covering Inovalon Holdings (NASDAQ:INOV), 0 have Buy rating, 2 Sell and 1 Hold. Therefore 0 are positive. Inovalon Holdings had 3 analyst reports since February 21, 2018 according to SRatingsIntel. Piper Jaffray maintained Inovalon Holdings, Inc. (NASDAQ:INOV) on Wednesday, February 21 with “Sell” rating. Morgan Stanley downgraded Inovalon Holdings, Inc. (NASDAQ:INOV) on Wednesday, March 14 to “Underweight” rating. The company was maintained on Wednesday, February 21 by Wells Fargo. Below is a list of Inovalon Holdings, Inc. (NASDAQ:INOV) latest ratings and price target changes.

14/03/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Underweight Old Target: $14 Downgrade
21/02/2018 Broker: Piper Jaffray Rating: Sell New Target: $8.0 Maintain
21/02/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Market Perform Old Target: $16 New Target: $14 Maintain

The stock increased 0.96% or $0.1 during the last trading session, reaching $10.5. About 536,375 shares traded. Inovalon Holdings, Inc. (NASDAQ:INOV) has declined 24.82% since June 3, 2017 and is downtrending. It has underperformed by 37.39% the S&P500.

Inovalon Holdings, Inc., a technology company, provides cloud platforms empowering a data-driven transformation from volume to value models throughout the healthcare industry. The company has market cap of $1.60 billion. The firm through, large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and industry-leading subject matter expertise, enables the assessment and improvement of clinical and quality outcomes, and financial performance across the healthcare ecosystem. It has a 44.12 P/E ratio. It serves health plans and well-known provider organizations, as well as pharmaceutical, medical device, and diagnostics companies.

Another recent and important Inovalon Holdings, Inc. (NASDAQ:INOV) news was published by which published an article titled: “Inovalon Reports First Quarter 2018 Results” on May 08, 2018.

Inovalon Holdings, Inc. (NASDAQ:INOV) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: